Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Defiance Nasdaq Junior Biotechnology ETF IBBJ
$29.87
На 18:02, 12 мая 2023
Ключевые показатели
-
Marketcap
0.00000000
-
week52high
41.45
-
week52low
27.85
-
Revenue
-
P/E TTM
0
-
Beta
0.00000000
-
EPS
0.00000000
-
Last Dividend
0.30000000
-
Next Earnings Date
07 мая 2023 г. в 03:50
Описание компании
The investment seeks to track the total return performance, before fees and expenses, of the NASDAQ Junior Biotechnology Index. The index is a rules-based index that consists of a portfolio of the stock of U.S.-listed small capitalization ("junior") companies screened from the universe of the NASDAQ Biotechnology Index. The fund will generally use a "replication" strategy to achieve its investment objective, meaning it will generally invest in all of the component securities of the index in the same approximate proportions as in the index. The fund is non-diversified.
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
ETF Odds & Ends: Closures Accelerate
ETFcom
07 дек 2021 г. в 10:23
Plus, a large number of name and index changes occurred during the past two weeks.
ETF Odds & Ends: Launches Resurge
ETFcom
30 окт 2021 г. в 01:20
Plus, expense ratio changes and other ETF developments occurred during the week.
Biotech ETFs Benefit From Moderna Dual Booster Shot News
ETF Trends
09 сент 2021 г. в 15:46
As the stock market attempts to reverse the recent pullback this month, Moderna shares climbed higher on Thursday after the company announced that it's creating a dual-purpose vaccine booster shot that offers protection against both the coronavirus and the seasonal flu. The new vaccine booster, which the biotech company calls mRNA-1073, combines Moderna's current coronavirus vaccine [.
Healthcare ETFs Surge on FDA Full-Vaccine Nod & Deal News
Zacks Investment Research
24 авг 2021 г. в 12:59
The FDA granted full approval of a COVID-19 vaccine made by Pfizer (PFE) and BioNTech that could accelerate inoculations in the United States.
Bet on Biotech Small Caps to Bounce Back
ETF Trends
19 авг 2021 г. в 14:43
Large cap biotechnology have strengthened in recent months, but smaller counterparts are still waiting on their 2021 moment. When that happens, the Defiance Nasdaq Junior Biotechnology ETF (IBBJ) could be the ETF to watch.